FRANKLIN LAKES, N.J.,
Feb. 15, 2019 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, announced today that it will present at
Leerink Partners 8th Annual Global Healthcare Conference
on Thursday, February 28, 2019, at
10:00 a.m. ET.
A live webcast of BD's presentation can be accessed from the BD
corporate website at www.bd.com/investors and will be available for
replay through Thursday, March 7,
2019.
About BD
BD is one of the largest global medical technology companies in
the world and is advancing the world of health by improving medical
discovery, diagnostics and the delivery of care. The company
supports the heroes on the frontlines of healthcare by developing
innovative technology, services and solutions that help advance
both clinical therapy for patients and clinical process for
healthcare providers. BD and its 65,000 employees have a passion
and commitment to help enhance the safety and efficiency of
clinicians' care delivery process, enable laboratory scientists to
accurately detect disease and advance researchers' capabilities to
develop the next generation of diagnostics and therapeutics. BD has
a presence in virtually every country and partners with
organizations around the world to address some of the most
challenging global health issues. By working in close collaboration
with customers, BD can help enhance outcomes, lower costs, increase
efficiencies, improve safety and expand access to healthcare. In
2017, BD welcomed C. R. Bard and its products into the BD family.
For more information on BD, please visit bd.com.
Contact:
Kristen Cardillo, Communications –
201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-to-present-at-leerink-partners-8th-annual-global-healthcare-conference-300796743.html
SOURCE BD (Becton, Dickinson and Company)